Wikisage, the free encyclopedia of the second generation, is digital heritage

Drisapersen: Difference between revisions

From Wikisage
Jump to navigation Jump to search
mNo edit summary
No edit summary
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
An exon skipping experimental [[drug|Medicine]]<ref>https://web.archive.org/web/20120729012249/http://www.prosensa.eu/technology-and-products/pipeline/pro051gsk2402968</ref>
An exon skipping experimental [[drug|Medicine]]<ref>https://web.archive.org/web/20120729012249/http://www.prosensa.eu/technology-and-products/pipeline/pro051gsk2402968</ref>
<ref>https://www.whocc.no/atc_ddd_index/?code=M09AX04</ref>
<ref>https://www.whocc.no/atc_ddd_index/?code=M09AX04</ref>
PRO051/GSK2402968 is considered an orphan drug
PRO051/GSK2402968 is considered an orphan drug.
Drisapersen
'''Drisapersen'''
differs from eteplirsen in that it is an 18-mer 2′O-methyl phosphorothioate type of AO, which is negatively charged <ref>[https://www.dovepress.com/eteplirsen-in-the-treatment-of-duchenne-muscular-dystrophy-peer-reviewed-fulltext-article-DDDT Eteplirsen in the treatment of Duchenne muscular dystrophy]</ref>
differs from eteplirsen in that it is an 18-mer 2′O-methyl phosphorothioate type of AO, which is negatively charged <ref>[https://www.dovepress.com/eteplirsen-in-the-treatment-of-duchenne-muscular-dystrophy-peer-reviewed-fulltext-article-DDDT Eteplirsen in the treatment of Duchenne muscular dystrophy]</ref>
==Links==
[[Duchenne muscular distrophy]]
[[Duchenne muscular distrophy]]
==Links==
 
[http://www.neurologyindia.com/article.asp?issn=0028-3886;year=2019;volume=67;issue=3;spage=717;epage=723;aulast=Arora Duchenne muscular dystrophy: Still an incurable disease]
[http://www.neurologyindia.com/article.asp?issn=0028-3886;year=2019;volume=67;issue=3;spage=717;epage=723;aulast=Arora Duchenne muscular dystrophy: Still an incurable disease]



Latest revision as of 23:42, 11 September 2019